广济药业
(000952)
| 流通市值：25.42亿 | | | 总市值：25.62亿 |
| 流通股本：3.44亿 | | | 总股本：3.47亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 329,052,431.63 | 278,492,602.16 | 259,092,013.56 | 519,982,780.81 |
| 应收票据及应收账款 | 221,077,103.07 | 226,571,005.71 | 167,546,380.76 | 195,054,538.59 |
| 其中：应收票据 | 12,271,825.36 | 17,171,239.44 | 22,456,329.73 | 28,405,484.63 |
| 应收账款 | 208,805,277.71 | 209,399,766.27 | 145,090,051.03 | 166,649,053.96 |
| 应收款项融资 | 28,750,976.18 | 30,241,697.74 | 9,546,348.32 | 4,097,632.47 |
| 预付款项 | 51,277,960.88 | 33,776,724.26 | 44,498,368.97 | 42,040,841.88 |
| 其他应收款合计 | 7,750,702.66 | 6,479,936.74 | 8,982,062.87 | 6,607,194.42 |
| 存货 | 213,418,151.41 | 257,654,036.59 | 317,347,806.07 | 354,729,548.45 |
| 其他流动资产 | 6,895,986.9 | 11,272,888.29 | 14,848,745.92 | 20,095,144.11 |
| 流动资产合计 | 858,223,312.73 | 844,488,891.49 | 821,861,726.47 | 1,142,607,680.73 |
| 非流动资产: | | | | |
| 长期股权投资 | 46,488,842.99 | 46,848,509.94 | 47,263,746.8 | - |
| 其他权益工具投资 | 7,280,000 | 7,280,000 | 7,280,000 | 7,280,000 |
| 固定资产 | 1,123,017,400.6 | 1,154,245,473.83 | 1,439,530,596.68 | 1,491,476,468.07 |
| 在建工程 | 18,854,424.06 | 16,409,576.02 | 22,569,007.25 | 33,943,868.51 |
| 使用权资产 | 1,326,770.76 | 1,477,185.72 | 1,676,928.56 | 1,845,841.46 |
| 无形资产 | 202,373,404.51 | 203,819,383.71 | 205,271,518.97 | 236,437,489.24 |
| 开发支出 | - | - | - | 5,191,398.51 |
| 长期待摊费用 | 5,001,870.94 | 4,811,464.14 | 5,230,648.1 | 10,525,232.22 |
| 递延所得税资产 | 25,297,389.93 | 24,779,985.11 | 20,599,143.08 | 20,116,173.69 |
| 其他非流动资产 | 6,558,095.1 | 8,344,211.67 | 9,041,324.26 | 9,821,422.74 |
| 非流动资产合计 | 1,436,198,198.89 | 1,468,015,790.14 | 1,758,462,913.7 | 1,816,637,894.44 |
| 资产总计 | 2,294,421,511.62 | 2,312,504,681.63 | 2,580,324,640.17 | 2,959,245,575.17 |
| 流动负债: | | | | |
| 短期借款 | 567,209,937.22 | 521,984,834.85 | 468,687,948.82 | 431,332,408.96 |
| 应付票据及应付账款 | 166,878,369.28 | 182,355,338.03 | 118,330,425.22 | 158,562,713.84 |
| 其中：应付票据 | 53,746,760.86 | 51,979,289.86 | 25,612,020.7 | 41,535,807.22 |
| 应付账款 | 113,131,608.42 | 130,376,048.17 | 92,718,404.52 | 117,026,906.62 |
| 合同负债 | 26,386,123 | 10,678,025.84 | 10,547,795.81 | 7,260,059.51 |
| 应付职工薪酬 | 21,707,245.81 | 24,388,036.18 | 21,124,713.47 | 22,329,492.57 |
| 应交税费 | 8,899,510.63 | 8,141,751.59 | 11,215,908.93 | 8,471,676.03 |
| 其他应付款合计 | 64,617,090.86 | 65,838,401.2 | 72,128,599.38 | 361,794,027.73 |
| 应付股利 | 3,248,886.9 | 3,248,886.9 | 3,248,886.9 | 3,248,886.9 |
| 一年内到期的非流动负债 | 529,324,194.82 | 565,941,009.74 | 513,522,099.89 | 482,740,891.08 |
| 其他流动负债 | 6,131,419.79 | 6,989,910.53 | 9,668,352.9 | 20,749,379.3 |
| 流动负债合计 | 1,391,153,891.41 | 1,386,317,307.96 | 1,225,225,844.42 | 1,493,240,649.02 |
| 非流动负债: | | | | |
| 长期借款 | 141,976,351.61 | 209,297,701.94 | 272,843,203.5 | 345,022,255 |
| 租赁负债 | 739,550.47 | 990,096.03 | 1,093,060.8 | 1,387,461.01 |
| 长期应付款 | 154,470,116.09 | 76,004,985.26 | 104,361,795.07 | 115,789,109.53 |
| 预计负债 | 110,000 | 110,000 | - | - |
| 递延收益 | 11,952,102.34 | 12,569,687.3 | 13,187,272.26 | 12,125,392.93 |
| 递延所得税负债 | 334,645.29 | 363,391.25 | 412,940.41 | 441,686.37 |
| 非流动负债合计 | 309,582,765.8 | 299,335,861.78 | 391,898,272.04 | 474,765,904.84 |
| 负债合计 | 1,700,736,657.21 | 1,685,653,169.74 | 1,617,124,116.46 | 1,968,006,553.86 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 346,630,639 | 346,750,339 | 346,750,339 | 346,750,339 |
| 资本公积 | 361,590,414.41 | 361,064,890.83 | 365,419,274 | 365,419,274 |
| 减:库存股 | 9,471,903 | 9,893,247 | 9,893,247 | 9,893,247 |
| 其他综合收益 | -11,141.08 | -17,811.78 | -17,781.32 | -17,760.72 |
| 专项储备 | 2,711,289.91 | 2,096,644.41 | 2,205,864.06 | 1,717,812.59 |
| 盈余公积 | 150,873,094.71 | 150,873,094.71 | 150,873,094.71 | 150,873,094.71 |
| 未分配利润 | -228,746,062.13 | -197,102,448.83 | 110,093,317.34 | 131,876,878.74 |
| 归属于母公司股东权益合计 | 623,576,331.82 | 653,771,461.34 | 965,430,860.79 | 986,726,391.32 |
| 少数股东权益 | -29,891,477.41 | -26,919,949.45 | -2,230,337.08 | 4,512,629.99 |
| 股东权益合计 | 593,684,854.41 | 626,851,511.89 | 963,200,523.71 | 991,239,021.31 |
| 负债和股东权益合计 | 2,294,421,511.62 | 2,312,504,681.63 | 2,580,324,640.17 | 2,959,245,575.17 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-27 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |